|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Development of male contraceptive vaccine -- a perspective. |
| Moudgal NR; Jeyakumar M; Krishnamurthy HN; Sridhar S; Krishnamurthy H; |
| HUMAN REPRODUCTION UPDATE. 1997 Jul-Aug;3(4):335-46. |
| Recent advances in basic understanding of gonadotrophin action have facilitated the development of candidates for |
| a male contraceptive vaccine. This article reviews the current status of the following such candidates: luteinizing |
| hormone-releasing hormone (LHRH), follicle-stimulating hormone (FSH), and LH and FSH receptor proteins. Studies |
| based primarily on non-human primates indicate the vaccines are well tolerated, with no known toxic symptoms or |
| immediate health hazards. The addition of acceptable immune stimulators to the adjuvant cocktail and the |
| development of better immunization schedules or immunogen delivery systems may enable increases in antibody |
| titers and prolongation of the immune response. The task at this point is careful evaluation of the bioefficacy of |
| antibodies raised to recombinant ovine FSH-beta or FSH receptor protein fragments in both human and non-human |
| primates. The FSH/FSH receptor has the advantage of not requiring an exogenous testosterone supplement to |
| maintain accessory gland function or libido. The LHRH/LH-based vaccine results in azoospermia, while the FSH |
| vaccine causes the production of low numbers of poor quality spermatozoa incapable of impregnating cycling |
| females. The most likely regimen includes the administration of two injections of the immunogen 20 days apart |
| followed by boosters of either LHRH or FSH once every 3-6 months. (PubHealth.info Document ID: CONT2T 553-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Development of male contraceptive vaccine -- a |
| perspective.", is(are) Moudgal NR; Jeyakumar M; Krishnamurthy HN; Sridhar S; Krishnamurthy H; Martin F. The |
| source of this article is "HUMAN REPRODUCTION UPDATE. 1997 Jul-Aug;3(4):335-46.". This article was published |
| in 1997 in English language(s). (PubHealth.info® Document ID: CONT2T 553-06. All rights reserved with |
| PubHealth.info) PIN: 5553 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |